Asset
Phentermine hydrochloride
Citius Pharmaceuticals Inc. Common Stock
Revenue
No revenue reported in loaded filings.
Clinical trials (0)
No records yet.
FDA applications (1)
| Application | Type | Applicant |
|---|---|---|
| NDA 202088 | NDA | CITIUS PHARMACEUTICALS LLC |
Marketed products (3)
- SUPRENZA
- SUPRENZA
- SUPRENZA